Skip to main content
OpenTrials
Completed

NCT Number: NCT07318766

Incentive Spirometer in Liver Transplant Recipients

This study evaluated the effect of adjunctive incentive spirometer on arterial blood gases (ABGs) and early postoperative recovery in liver transplant recipients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

El Sahel Teaching hospital

Cairo, Egypt

About this study

In this prospective , randomized study, 40 adults undergoing living-donor liver transplantation (LT) were assigned to standard post-transplant mobilization and breathing exercises alone (n=20) or standard exercises plus structured IS training (n=20). Arterial blood gases ABG parameters (pH, PO₂, PCO₂, HCO₃-, SpO₂) were measured at baseline and on postoperative days 1-3. Linear mixed-effects models assessed group differences in ABG trajectories; slope analyses quantified decline and recovery phases. Secondary outcomes included intensive care unit (ICU) and hospital length of stay (LOS) and Post-operative pulmonary complications incidence.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age between 18 and 65 years,
  • scheduled to undergo Living Donor Liver Transplant (LDLT) as recipients
  • able to understand and follow instructions for incentive spirometry use

Exclusion criteria

  • multiorgan transplantation
  • moderate-to-severe pleural effusion at baseline
  • persistent elevation in renal function tests
  • history of bleeding esophageal varices within the preceding month
  • multicentric hepatocellular carcinoma (HCC)
  • active smoking
  • decompensated cardiac disease
  • alcoholic hepatitis as the primary etiology
  • cognitive impairment or blindness precluding participation in the rehabilitation protocol.

Treatment and study plan

Incentive spirometry

Device

An intensive spirometry (IS) is a device that measures inhaled air volume and provides visual feedback as a piston rises during inspiration. It is widely used in respiratory and physical therapy to encourage slow, deep breathing, which helps expand the lungs, open airways, and mimic the natural deep breaths seen in yawning or sighing.

Primary outcomes

  1. Arterial blood gas (ABG) parameters

    Time frame: 3 days (assessed at four time points: baseline (within 48 hours before surgery) and on post-operative days 1, 2, and 3)

    Arterial pH

  2. Arterial Blood Gas (ABG) parameters

    Time frame: 3 days (assessed at four time points: baseline (within 48 hours before surgery) and at day 1,2, and 3 post-surgery)

    (2) partial pressure of carbon dioxide (PCO2, mmHg)

  3. Arterial Blood Gas (ABG) parameters

    Time frame: 3 days (assessed at four time points: baseline (within 48 hours before surgery) and at day 1, 2, and 3 post-surgery)

    (3) Partial pressure of oxygen (PO2, mmHg)

  4. Arterial Blood Gas (ABG) Parameters

    Time frame: 3 days (assessed at four time points: baseline (within 48 hours before surgery) and at day 1, 2, and 3 post-surgery)

    (4) bicarbonate concentration (HCO3-, mEq/L)

  5. Arterial Blood Gas (ABG) Parameters

    Time frame: 3 days (assessed at four time points: baseline (within 48 hours before surgery) and at day 1, 2, and 3 post-surgery)

    (5) Oxygen saturation (SpO2, %).

Secondary outcomes

  1. length of intensive care unit (ICU) stay

    Time frame: Perioperative period (Hospital stay duration)

    The length of intensive care unit (ICU) stay (days)

  2. hospital stay

    Time frame: Perioperative period (Hospital Stay duration)

    total length of hospital stay (days)

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Collaborators

  • El-Sahel Teaching Hospital
  • National Hepatology & Tropical Medicine Research Institute

Registry information

Official study title

Effect of Incentive Spirometer on Arterial Blood Gases in Liver Transplant Recipients

Acronym: LT

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jan 6, 2026
Registry last updated
Jan 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.